Fordham University (Psychology), B.A.

Stanley E. Bradley Award for Bench Research, Department of Internal Medicine,
Hospital of the University of Pennsylvania, 2004

American Academy of Allergy, Asthma and Immunology (AAAAI)
Fellow in Training Travel Scholarship, 2004

AAAAI National Resident Educational Program Mentorship and Travel Grant, 2004

AAAAI Chrysalis Project Award and Travel Grant, 1999

American Federation for Medical Research (AFMR)
Young Investigator Award and Travel Grant, 1997

American Society of Hematology
Summer Scholarship Award and Stipend, 1994

American Federation for Clinical Research
Medical Student Research Award, 1994

Clinical Immunology Society
Bench to Bedside Award, 1993

American Society of Hematology
Summer Scholarship Award and Stipend, 1993

Role of Atrial Natriuretic Peptide in Non-IgE-Mediated Mast Cell Activation. 8/2005-present

Identification of Inflammatory Gene Expression Profiles in Nasal Polyp Tissue from Children with Cystic Fibrosis. 3/2005 - 6/2006

Identification of Steroid-Inducible Genes in Human Nasal Polyp Tissue. 1/2005-present

"A Long Term Safety Study of XXXXXXX and XXXXXX XXXXXX in Subjects Twelve Years of Age and Older with Asthma" 2004- 2005

"Twelve-Week, Randomized, Double-Blind, Double-Dummy, Placebo and Active Controlled Study of XXXXXXXX pMDI Administered Once Daily in Adults and Adolescents with Asthma - XXXX" 2004- 2005

"A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Single-Dummy, Multicenter, 12 Week Study to Assess the Efficacy and Safety of XXXXXXXX pMDI 160/4.5 g x 2 Actuations Once-Daily (QD) Compared to XXXXXXXX pMDI 80/4.5 g x 2 Actuations QD, XXXXXXX pMDI 80/4.5 g x 2 Actuations Twice-Daily (BID) and to XXXXXXX pMDI 160 g x 2 Actuations QD in Asthmatic Subjects 12 years of Age and Older" 2004- 2005

"An Ascending Four Dose Placebo Controlled Study to Assess the Efficacy and Tolerability of XX-XX (recombinant plasma kallikrein inhibitor) Administered Following Onset of Acute Attacks of Hereditary Angioedema" 2004- Present

"A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of XXXXXXX XXXXXX/XXXXXX DISKUS Combination Product 100/50mcg BID versus XXXXXXXX XXXXXXXX DISKUS 100mcg BID in Pediatric and Adolescent Subjects with Activity Induced Bronchospasm" 2004- 2006

"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Multiple Dose (7 days) Dose-Ranging study, To Assess the Efficacy and Safety of 4 Doses of XXXXXX (50, 100, 200 & 400 µg) Delivered via a Multiple Dose Inhaler and 1 Dose of XXXXXX (400 µg) Delivered via a Single Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease (COPD)" 2004- 2005

"A Randomized, Double-Blind, Parallel Group, 52-week Study to Compare the Effect of the Fluticasone Propionate/Salmeterol DISKUS Combination Product 250/50mcg BID with Salmeterol DISKUS 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD)" 1/2005- 6/2006

"XXXXXXXX in combination with nasal glucocorticosteroid for perennial allergic and non-allergic rhinitis in subjects with persistent nasal congestion" 2/2005- Present

"A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of XXXXX(15mg BID) in Patients with Chronic Obstructive Pulmonary Disease (COPD)" 2005- 2006

"A 12-Month Double-blind, Double-Dummy, Randomized, Parallel group, Multicenter Efficacy and Safety Study of XXXXXXXX pMDI 2 x160/4.5 µg bid and 2 x 80/4.5 µg bid Compared to XXXXXXXXX 2 x 4.5µg bid and Placebo in Patients with COPD" 2005- Present

"Study of Acid Reflux and Asthma" 6/2005- Present

"A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy of XXXXXXXXX metered-dose inhaler at a daily dose of 160 µg administered for 12 weeks either in a once-daily regimen in the morning (160 µg qd AM) or in a twice-daily regimen (80 µg bid) in adults and adolescents with mild to moderate persistent asthma treated previously with inhaled corticosteroids" 2005- Present

"A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of XXXXXXXX Inhalation Powder 200mcg, 400mcg, 600mcg and 800mcg Administered Once Daily in the Morning and XXXXXXX XXXXXXXX 500mcg BID via DISKUS Inhalation Powder Compared with Placebo for 8 Weeks in Adolescent and Adult Subjects (?12 years old) with Persistent Asthma Symptomatic on Moderate-Dose ICS Therapy" 2005- Present

"A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of XXXXXXX Inhalation Powder 25mcg, 50mcg, 100mcg, and 200mcg Administered Once Daily in the Morning and XXXXXXX XXXXXX 100mcg BID via DISKUS Inhalation Powder compared with Placebo for 8 Weeks in Adolescent and Adult Subjects (?12 years old) with Persistent Asthma Symptomatic on Non-ICS Therapy" 2005- Present

"Safety and Dosing Study for Sublingual-Oral Administration of Standardized Glycerinated Cat Hair Allergenic Extract" 2005- 7/2006

"Impact of an Asthma Camp on Knowledge and Clinical Outcomes" 7/2005

"A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of XXXX (15mg BID) in Patients with Chronic Obstructive Pulmonary Disease (COPD)" 4/2005- Present

"Sinusitis and Rhinitis in Asthma" 12/2005- 2/2006

"Evaluation of XX-XX'S Effects in Mitigating Angioedema A double-blind, placebo-controlled study followed by a repeat dosing phase to assess the efficacy and safety of XX-XX (recombinant plasma kallikrein inhibitor) for the treatment of acute attacks of Hereditary Angioedema" 2005- Present

"A Randomized, Parallel Group, Double-Blind, Comparative Trial Assessing Lung Function and Other Measures of Asthma Control in Adults and Adolescents, at least 12 Years of Age, with Persistent Asthma, Who Have Either a B16-Arg/Arg, a B16-Gly/Gly or a B-16 Arg/Gly Genotype and are Treated With XXXXXX 100/50mcg or XXXXXX 50 mcg BID" 1/2005-7/2006

"A randomized, placebo-controlled, double-blind Phase II study of the efficacy and safety of XXXXXX for the treatment of acute attacks in patients with hereditary angioedema" 2/2006- Present

"A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of XXXXXXX Nasal Spray 200mcg QD versus XXXXXX 10mg QD in Adolescent and Adult Subjects with Asthma and Seasonal Allergic Rhinitis Who are Receiving XXXXXXX 100/50mcg BID or Placebo BID" 3/2006- Present

"A prospective observational study for the psychometric validation of a patient-reported questionnaire in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)" 3/2006- Present

"A 26-week, randomized, double-blind, parallel-group, placebo-controlled, multi-center study to evaluate the effect of XXXXXX on improving the tolerability of specific immunotherapy in patients with at least moderate persistent allergic asthma inadequately controlled with inhaled corticosteroids" 4/2006-Present

"A Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel Group Long-Term Safety Study of 15 µg and 25 µg XXXXXXXX Inhalation Solution BID in the Treatment of Subjects with Chronic Obstructive Pulmonary Disease" 5/2006- Present

"A Randomized, Double-blind, Placebo-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of XXXXX and XXXXXX Combination (XXXXX 100/10 g or 250/10 g twice daily) in a Single Inhaler (XXXX HFA pMDI) with the Administration of Placebo or XXXXX (250 g twice daily) and XXXXXl (10 g twice daily) Alone in Adolescent and Adult Patients with Moderate to Severe Asthma" 6/2006- Present

"Effect of XXXXX on exacerbation rate in patients with COPD. A 52-week, Double-blind Study with 500 mcg XXXXXX Once Daily versus Placebo" 7/2006- Present

"A Phase IIIb Multicenter, Randomized, Double- Blind, Placebo- Controlled Study of XXXXXX in Subjects with Moderate to Severe Persistent Asthma Who Are Inadequately Controlled with High- Dose Inhaled Corticosteroids and Long- Acting Beta- Agonists" 7/2006- Present

Steroids and Inflammation. James H. Haley VA Medical Center Internal Medicine Noon Conference, Tampa, Florida, 5/2006

Allergic Rhinitis. Tampa General Internal Medicine Noon Conference, Tampa General Hospital, Tampa, Florida, 2/2006

Update in Asthma Treatment Guidelines: What Do They Mean? American College of Physicians, 2005 Florida Chapter Scientific Session, Sarasota, Florida, 9/2005

Overview of Asthma Treatment Strategies. Internal Medicine Grand Rounds Orlando Regional Medical Center, Orlando, Florida, 8/2005

Steroid Resistance: How Does it Happen? Scientific Conference Series. Orlando Regional Medical Center, Orlando Florida, 8/2005

Overview of Biologics: Adverse Reactions and Toxicities. Annual Meeting of the Florida Allergy Asthma and Immunology Society. Boca Raton, Florida, 6/2005

Glucocorticoid Resistance. Annual Meeting of the Florida Allergy Asthma and Immunology Society. Boca Raton, Florida, 6/2005

Steroids and Inflammation. James H. Haley VA Medical Center Internal Medicine Noon Conference, Tampa, Florida, 5/2005

Asthma Treatment. USF Allergic Rhinitis and Asthma: Pathogenesis, Diagnosis and Treatment Symposium. Tampa General Hospital, Tampa, Florida, 4/2005

Perspectives on Gene Therapy in Asthma. American Academy of Allergy, Asthma and Immunology 2005 Annual Meeting. San Antonio, Texas, 3/2005

Environmental Triggers and Allergic Disease: Role of Innate Immunity and Potential Therapies. American Academy of Allergy, Asthma and Immunology 2005 Annual Meeting. San Antonio, Texas, 3/2005

Approach to Immunodeficiency. Tampa General Internal Medicine Noon Conference, Tampa General Hospital, Tampa, Florida, 11/2004

Immunodeficieny for the Internist. James A. Haley VA Medical Center Internal Medicine Noon Conference, VA Medical Center, Tampa, FL, 11/2004

Food Allergy - Are Vaccines OK, What Can They Eat? Pediatric Allergy and Immunology Symposium: Sarasota Memorial Hospital, Sarasota, Florida, 9/2004

Signaling of Human Naïve and Memory B cells via Toll-like Receptor 7 Mediates their Immunoglobulin Production. Meeting of the 12th International Congress of Immunology and 4th Annual Conference of the Federation of Clinical Immunology Societies (FOCIS). Montreal, Canada, 7/2004.

Glucocorticoid Resistance in Asthma: Current Concepts and Treatment.
Department of Internal Medicine Grand Rounds, University of South Florida College of Medicine. Tampa, Florida, 7/2004

Allergic Triggers in Asthma and Environmental Controls. Mini Medical School, Tampa General Hospital, Tampa, Florida 5/2006

Environmental Allergen Controls. USF A&I Joint Conference Series, Tampa, Florida 2/2006

Asthma Treatment. USF A&I Joint Case Conference Series, Tampa, Florida 8/2005

Update on Asthma Guidelines. USF A&I Joint Conference Series. Tampa, Florida 2/2005

Immunotherapy, Insect Allergy and Food Allergy: Human Correlates. 2005 North American Veterinary Dermatology Forum. Sarasota Hyatt Hotel and Convention Center, Sarasota, Florida, 4/2005

Allergic Asthma Triggers and Environmental Control. American Lung Association Night School for your Health, Tampa General Hospital, Tampa, Florida, 3/2005

Steroid Resistant Asthma. USF A&I Joint Case Conference, Tampa, Florida 2/2005

Allergic Triggers and What You Can Do About Them. American Lung Association Asthma U. Bayview Hospital, Saint Petersburg, Florida 10/2004

Airway Remodeling in Asthma. USF A&I Joint Case Conference, Tampa Florida 10/2004

Allergic Rhinitis: What Is It and What Causes It? USF Lunch and Learn Series, Tampa Florida 10/2004

Hospital of the University of Pennsylvania Faculty and Staff Allergy Workshop Philadelphia, Pennsylvania, 4/2004.

Management Strategies in Steroid-Resistant Asthma. University of South Florida, Division of Allergy and Immunology, Tampa, Florida, 8/2003.

TGF- mRNA and Protein Generation by Human Lung Mast Cells
Conference of the American Thoracic Society: Chicago, Illinois, 5/1998.

IgE-Induced TH2 Cytokine Generation by Human Lung Mast Cells
Aspen M.D./Ph.D. Student Conference: Aspen, Colorado, 7/1994.

IgE-Dependent Expression of Interleukin-5 mRNA
in Human Lung is Modulated by Dexamethasone
Conference of the American Academy of Allergy, Asthma & Immunology: Anaheim, California, 5/1994.

Interleukin 5 is Expressed at a Transcriptional Level in Human Lung
Conference of the AAAAI/AAI/CIS: Denver, Colorado, 5/1993.

Signaling of Human Naïve and Memory B cells via Toll-like Receptor 7 Mediates their Immunoglobulin Production.
10^th Annual Respiration Research Retreat of the University of Pennsylvania, Sugarloaf Conference Center, Philadelphia, Pennsylvania, 6/2004.

Signaling of Human B cells via Toll-like Receptors 7 and 8 Modulates Immunoglobulin Production.
University of Pennsylvania, Department of Medicine Research Day, Philadelphia, Pennsylvania, 5/2004.

Longstanding Common Variable Immunodeficiency (CVID) Sans Recurrent Sinopulmonary Infection.
Conference of the American Academy of Allergy Asthma & Immunology: San Francisco, California, 3/2004.

Signaling of Human B cells via Toll-like Receptors 7 and 8 Modulates
Immunoglobulin Production.
Conference of the American Academy of Allergy Asthma & Immunology: San Francisco, California, 3/2004

Inducible TGF- mRNA and Protein from Human Lung Mast Cells
Conference of the AFMR; Biomedicine'97: Washington, DC, 5/1997.

Differential Effects of Dexamethasone: Cytokine Generation vs. Histamine Release.

Conference of the American Academy of Allergy Asthma & Immunology: San
Francisco, California,2/1997.

Glaum, M.C., Jaffe, J.S., Gillespie, D.H., Raible, D.G., Post, T.J., Wang, Y, Dimitry, E., Schulman, E.S.: IgE-Dependent Expression of Interleukin-5 mRNA and Protein in Human Lung: Modulation by Dexamethasone.
Clin Immunol Immunopathol 75: No. 2, 171-178, 1995.

Jaffe J.S., Glaum, M.C., Raible, D.G., Post, T.J., Dimitry, E., Govindarao, D., Wang, Y., Schulman, E.S.: Human Lung Mast Cell IL-5 Gene and Protein Expression: Temporal Analysis of Upregulation following IgE-mediated Activation.
Am J Respir Cell Mol Biol 13: 665-675, 1995.

Jaffe, J.S., Raible, D.G., Post, T.J., Wang, Y, Glaum, M.C., Butterfield, J.H., Schulman, E.S.: Human Lung Mast Cell Activation Leads to IL-13 mRNA Expression and Protein Release. Am J Respir Cell Mol Biol 15: 473-481, 1996.

Schulman, E.S., Glaum, M.C., Post, T., Wang, Y., Raible, D.G., Mohanty, J., Butterfield, J.H., Pelleg, A.: ATP Modulates Anti-IgE-Induced Release of Histamine from Human Lung Mast Cells.
Am J Respir Cell Mol Biol 20: 530-537, 1999.

Raible, D.G., Mohanty, J., Jaffe, J.S., Stella, H.J., Sprenkle, B.E, Glaum, M.C., Schulman, E.S.: Hydrogen Peroxide Release from Human Eosinophils on Fibronectin: Scopoletin Enhances Eosinophil Activation.
Free Radic Biol Med 28(11): 1652-1660, 2000.

Glaum, M.C., Wang, Y., Raible, D.G., Schulman, E.S.: Degranulation Influences Heparin-Associated Inhibition of RT-PCR in Human Lung Mast Cells.

Clin Exper Allergy 31: 1631-1635, 2001.

Glaum, M.C.:Expression and Modulation of Asthma-related Cytokines by Human Lung Mast Cells.
A thesis presented for the Doctor of Philosophy degree, MCP/Hahnemann University Library; 2001

Glaum, M.C., Apter, A., Levinson, A.I. Asymptomatic Longstanding Panhypogammaglobulinemia with Impaired Antibody Responses. (submitted)

Glaum, M.C., Gillespie, D.H., Schulman, E.S.: Interleukin 5 is expressed at a transcriptional level in human lung.
J Immunol 150(8) :1009, 1993.

Dimitry, E.A., Jaffe, J.S., Post, T.J., Glaum, M.C., Wang ,Y., Gillespie, D., Schulman, E.S.: Beta-adrenergic agonist-induced attenuation of Interleukin 5 mRNA and protein from anti-IgE challenged human lung fragments.
Am J Resp Crit Care Med 149(4):A804, 1994.

Glaum, M.C., Gillespie, D.H., Schulman, E.S.: IgE-dependent expression of Interleukin-5 mRNA in human lung is modulated by dexamethasone.
J Allergy Clin Immunol 184:128, 1994.

Remy, F.J., Jaffe, J.S., Raible, D.G., Post, T.J, Wang, Y., Glaum, M.C., Schulman, E.S.: Propranolol enhances histamine and Interleukin 5 generation from anti-IgE challenged human lung fragments: Evidence for inverse agonist effect.
J Allergy Clin Immunol 97(1):424, 1996.

Glaum, M.C., Jaffe, J.S., Raible, D.G., Wang ,Y., Post, T., Schulman, E.S.: Differential effects of dexamethasone on human lung mast cells: Cytokine production vs. histamine release.
J Allergy Clin Immunol 99(1), pt.2:214, 1997.

Glaum, M.C., Jaffe, J.S., Wang, Y., Post, T.J., Schulman, E.S.: Inducible TGF- production by human lung mast cells.
J Invest Med 45(3):287A, 1997.

Schulman, E.S., Glaum, M.C., Post, T., Wang ,Y., Raible, D., Mohanty, J., Pelleg, A.: P2-purinoceptor-mediated enhancement of anti-IgE stimulated human lung mast cell histamine release.
Sixth International Symposium on Adenosine and Adenine Nucleotides: December 1997.

Schulman, E.S., Glaum, M.C., Post, T.J., Wang, Y., Yassin, R., Mohanty, J., Pelleg, A.: Mechanisms of ATP's enhancement of histamine release from human lung mast cells.
Am J Resp Crit Care Med 157(3):A397, 1998.

Raible, D.G., Mohanty, J.G., Jaffe, J.S., Stella, H.J., Sprenkle, B.E., Glaum, M.C., Schulman, E.S.: Fibronectin-induced hydrogen peroxide release from eosinophils: The detection method matters.
Am J Resp Crit Care Med 157(3):A522, 1998.

Glaum, M.C., Jaffe, J.S., Raible, D.G., Wang, Y., Post, T., Schulman, E.S.: TGF- mRNA and protein generation by purified human lung mast cells.
Am J Resp Crit Care Med 157(3):A264, 1998.

Glaum, M.C., LaRosa, D.F., Apter, A.J., Levinson, A.I.: Longstanding Common Variable Immunodeficiency (CVID) Sans Recurrent Sinopulmonary Infection.
J Allergy Clin Immunol 113(2):81, 2004.

Lynn, J., Glaum, M.C., Levinson, A.I.: Signaling of Human B cells via Toll-like Receptors 7 and 8 Modulates Immunoglobulin Production.
J Allergy Clin Immunol 113(2):114, 2004.

Glaum, M.C., Levinson, A.I.: Signaling of Human Naïve and Memory B cells via Toll-like Receptor 7 Modulates Their Immunoglobulin Production.
Clin Invest Med, 27 (4): 3066, 2004.

Glaum, M.C., Nimal, S., Lockey, R., Mohapatra, S.: Atrial Natriuretic Peptide Activates Human Mast Cells via an IgE-Independent Mechanism. Clin Immunol, 19: S53, 2006.